Discovery and Optimization of Imidazopyridine-Based Inhibitors of Diacylglycerol Acyltransferase 2 (DGAT2) | Journal of Medicinal Chemistry
Brain Sciences | Free Full-Text | Clinical Study of Intraoperative Microelectrode Recordings during Awake and Asleep Subthalamic Nucleus Deep Brain Stimulation for Parkinson’s Disease: A Retrospective Cohort Study
0008 - Electronic Case Filings
Parkinson disease-associated cognitive impairment | Nature Reviews Disease Primers
PDF) Mild Cognitive Impairment: Incidence and Risk factors Results of the Leipzig Longitudinal Study of the Aged (LEILA75+)
Discovery and Optimization of Imidazopyridine-Based Inhibitors of Diacylglycerol Acyltransferase 2 (DGAT2) | Journal of Medicinal Chemistry
Parkinson disease-associated cognitive impairment | Nature Reviews Disease Primers
JPM | Free Full-Text | Parkinson's Disease: Personalized Pathway of Care for Device-Aided Therapies (DAT) and the Role of Continuous Objective Monitoring (COM) Using Wearable Sensors
Small-Molecule Inhibitors of Reactive Oxygen Species Production | Journal of Medicinal Chemistry
Brain Sciences | Free Full-Text | Short- and Long-Term Efficacy and Safety of Deep-Brain Stimulation in Parkinson’s Disease Patients aged 75 Years and Older
Indian Trails and MDOT Roll Out Eight "Pure Michigan" Buses
Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association | Circulation
Brain Sciences | Free Full-Text | Vortioxetine Improves Depressive Symptoms and Cognition in Parkinson’s Disease Patients with Major Depression: An Open-Label Prospective Study
Cognitive function in the early phase of Parkinson's disease, a five-year follow-up | Request PDF
Can someone tell me what kind of tower this is? : r/cellmapper
Frontiers | Development and Co-design of NeuroOrb: A Novel “Serious Gaming” System Targeting Cognitive Impairment in Parkinson's Disease
Parkinson disease-associated cognitive impairment | Nature Reviews Disease Primers
Analysis of Metabolite and Lipid Association Networks Reveals Molecular Mechanisms Associated with 3-Month Mortality and Poor Functional Outcomes in Patients with Acute Ischemic Stroke after Thrombolytic Treatment with Recombinant Tissue Plasminogen ...
